Free Trial

Feedback (FDBK) Competitors

Feedback logo
GBX 14.10 -0.40 (-2.76%)
As of 07/11/2025 05:32 AM Eastern

FDBK vs. COG, INHC, IQAI, DVRG, TRLS, SENS, EMIS, CRW, INS, and KOO

Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Cambridge Cognition (COG), Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), and Kooth (KOO). These companies are all part of the "health information services" industry.

Feedback vs. Its Competitors

Cambridge Cognition (LON:COG) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

Cambridge Cognition has a net margin of -10.07% compared to Feedback's net margin of -279.16%. Feedback's return on equity of -39.71% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Cognition-10.07% -68.83% -0.30%
Feedback -279.16%-39.71%-22.99%

Cambridge Cognition has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.

35.2% of Cambridge Cognition shares are held by institutional investors. Comparatively, 53.2% of Feedback shares are held by institutional investors. 29.9% of Cambridge Cognition shares are held by insiders. Comparatively, 10.8% of Feedback shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Cambridge Cognition has higher revenue and earnings than Feedback. Cambridge Cognition is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Cognition£15.64M0.87-£1.58M-£3.76-8.64
Feedback£3.88M1.59-£10.84M-£24.74-0.57

In the previous week, Cambridge Cognition's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
Cambridge Cognition Neutral
Feedback Neutral

Summary

Cambridge Cognition beats Feedback on 6 of the 11 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£6.18M£220.71M£5.56B£3.00B
Dividend Yield4.56%6.68%5.07%5.02%
P/E Ratio-0.57379.2421.21150.83
Price / Sales1.59196.12432.08314,599.98
Price / Cash1.1247.1437.1227.97
Price / Book0.255.278.044.58
Net Income-£10.84M-£15.55M£3.19B£5.90B
7 Day Performance-2.76%-0.06%3.63%11.51%
1 Month Performance-5.37%-0.33%4.06%7.92%
1 Year Performance-77.62%14.19%30.02%32.01%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 14.10
-2.8%
N/A-77.2%£6.18M£3.88M-0.5724Gap Down
COG
Cambridge Cognition
N/AGBX 32.95
+3.0%
N/A-22.8%£13.80M£15.64M-8.7680Gap Up
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A-2.5%£9.00M£12.57M-1.7674
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-27.3%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.55
-15.2%
N/A-68.2%£1.07M£65.83K-0.1631Gap Down
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
N/AGBX 2,190
flat
GBX 2,800
+27.9%
-3.1%£940.97M£230.77M80.91734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
2.8473 of 5 stars
GBX 194.10
+0.6%
GBX 456.67
+135.3%
-38.1%£71.24M£50.72M18.24478News Coverage
Analyst Forecast

Related Companies and Tools


This page (LON:FDBK) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners